1-6 of 6
Majed Alahmadi
Close
Sort by
Journal Articles

Evaluation of Efficacy and Safety of Nivolumab in Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma at King Abdulaziz Medical City-Jeddah/the Kingdom of Saudi Arabia Experience

Amani Reda Alsafi, Majed Alahmadi, Ahmed Absi, Ahmad S. Alsaeed, Sameer Alamoudi, Ihab Hemaidi, Walaa Rajkhan, Manar Khalil, Saleem Dadah, Ahmed Said Higazi, Mubarak Almansour, Roula Almufti
Journal: Blood
Blood (2023) 142 (Supplement 1): 6175.
https://doi.org/10.1182/blood-2023-190314
Published: 2023
Journal Articles

Brentuximab Vedotin Plus Bendamustine: As Salvage Regimen for Relapsed or Refractory Hodgkin Lymphoma, King Abdulaziz Medical City - Jeddah - KSA Experience

Muteb Althomali, Ahmad Absi, Ihab El Hemaidi, Ashraf Warsi, Sameer AlAmoudi, Majed Alahmadi, Walaa Rajkhan, Sultan Almutairi, Saleem Eldadah, Manar Khalil, Muna Adam, Syed Adnaan Ali, Abdulrahman Alghamdi, Ahmad Alsaeed
Journal: Blood
Blood (2019) 134 (Supplement_1): 5295.
https://doi.org/10.1182/blood-2019-121993
Published: 2019
Journal Articles

Addition of Cyclophosphamide, on Demand, to Lenalidomide and Corticosteroids in Patients with Relapsed/Refractory Multiple Myeloma, a Retrospective Review of a Single Centre Experience

Majed Alahmadi, MBBS, FRCPC, Esther Masih-Khan, PhD, Eshetu G Atenafu, M.Sc., P.Stat., Limore Arones, Christine Chen, MD, Vishal Kukreti, MD, Rodger Tiedemann, MBChB, PhD, Suzanne Trudel, MD, Anca Prica, MD, Donna Reece
Journal: Blood
Blood (2015) 126 (23): 1842.
https://doi.org/10.1182/blood.V126.23.1842.1842
Published: 2015
Journal Articles

Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study

Clinical Trials & Observations
Matthew Kang, Majed Alahmadi, Sonja Sawh, Michael J. Kovacs, Alejandro Lazo-Langner
Journal: Blood
Blood (2015) 125 (6): 924–929.
https://doi.org/10.1182/blood-2014-09-599498
Published: 2015
Includes: Supplemental data
Journal Articles

Effect of Unintentional Cyclophosphamide Under-Dosing on Disease Response and Outcomes in Patients with Diffuse Large B-Cell Lymphoma

Majed Alahmadi, MBBS, Joy Mangel, MD FRCPC, Ally Dhalla, Kevin Liu, Alejandro Lazo-Langer, MD, Leonard A Minuk, MD FRCPC
Journal: Blood
Blood (2014) 124 (21): 5441.
https://doi.org/10.1182/blood.V124.21.5441.5441
Published: 2014
Journal Articles

Fondaparinux Versus Argatroban and Danaparoid for the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia: A Propensity Score Analysis.

Matthew Kang, MD, Majed Alahmadi, MD, Sonja Sawh, BScPharm, Michael J. Kovacs, MD, Alejandro Lazo-Langner, MD, MSc
Journal: Blood
Blood (2012) 120 (21): 2262.
https://doi.org/10.1182/blood.V120.21.2262.2262
Published: 2012